Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Dermatological Drugs Market Through 2034?
The market for dermatological drugs has seen considerable expansion in the past few years. Projected growth is expected to take it from $20.06 billion in 2024 to $21.98 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth in the historical time frame include an increased occurrence of skin conditions, improvements in drug formulation and delivery methods, heightened public consciousness about skincare and aesthetics, a larger older population, and a heightened demand for over-the-counter dermatological items.
In the coming years, the dermatological drugs market is expected to experience substantial growth, forecasted to reach a size of $31.49 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.4%. The projected growth during this forecast period can be credited to the advancements in biologics and targeted therapies, the widening adoption of teledermatology and digital health, an uptick in lifestyle-related skin conditions, an increased demand for personalized and regenerative medicine, and extended research in microbiome-based dermatological treatments. The forecast period is also likely to witness significant trends like drug delivery through nanotechnology, artificial intelligence-driven dermatological diagnostics, therapies targeting microbiome, 3D bioprinting for skin regeneration, and treatments based on gene editing and RNA.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21166&type=smp
What are the Fundamental Drivers and Innovations Shaping the Dermatological Drugs Market?
The surge in demand for cosmetic dermatology procedures is predicted to accelerate the expansion of the dermatological drugs market. Cosmetic dermatology is a field of dermatology that specializes in improving an individual’s appearance using various non-surgical treatments. Increasing consumer awareness about aesthetic treatments, advancements in skincare technology, and an inclination towards non-invasive procedures for enhancing appearance and combating aging are fueling the demand for cosmetic dermatology. This escalating demand for services like anti-aging and skin rejuvenation treatments is propelling the creation of advanced dermatological drugs that provide safe, effective, and minimally invasive solutions. For example, the international Society of Aesthetic Plastic Surgery, a US-based professional organization, reported in January 2023 that over 12.8 million surgical and 17.5 million non-surgical procedures were performed worldwide, marking a 19.3% increase from the previous reporting period. In addition, more than 14.9 million surgical and 18.8 million non-surgical procedures will be performed globally by plastic surgeons in 2022, predicting an 11.2% growth in total procedures. Hence, the increasing number of cosmetic dermatology procedures is fueling the dermatological drugs market’s growth.
How Is the Dermatological Drugs Market Segmented?
The dermatological drugsmarket covered in this report is segmented –
1) By Drug Class: Corticosteroids; Retinoids; Antibiotics; Antifungals; Calcineurin Inhibitors; Other Drug Classes
2) By Administration: Topical Administration; Oral Administration; Parenteral Administration
3) By Indication: Acne; Psoriasis; Rosacea; Alopecia; Other Indications
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
Subsegments:
1) By Corticosteroids: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids
2) By Retinoids: Topical Retinoids; Oral Retinoids
3) By Antibiotics: Topical Antibiotics; Oral Antibiotics
4) By Antifungals: Topical Antifungals; Oral Antifungals
5) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors; Systemic Calcineurin Inhibitors
6) By Other Drug Classes: Biologics; JAK Inhibitors; Antihistamines; Photodynamic Therapy Agents
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21166&type=smp
Which Regions Are Driving the Next Phase of the Dermatological Drugs Market Growth?
North America was the largest region in the dermatological drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatological drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Dermatological Drugs Market?
Prominent firms in the dermatological drugs market are focusing on creating biologic treatments to tackle chronic skin issues including psoriasis, atopic dermatitis, and hidradenitis suppurativa. Biologics target specific immune pathways, providing more sustained and effective relief compared to conventional therapies. For example, in September 2024, Eli Lilly and Company, a pharmaceutical firm based in the US, was granted approval for Ebglyss (lebrikizumab), a drug that inhibits interleukin-13 (IL-13), for the treatment of moderate-to-severe atopic dermatitis in adults and children over 12. This endorsement signifies a major development by presenting a new biologic treatment alternative for patients whose symptoms have not been sufficiently controlled with topical therapies. Ebglyss is designed to boost the quality of life for patients by lessening severe itching and skin inflammation linked to moderate-to-severe atopic dermatitis.
View the full report here:
https://www.thebusinessresearchcompany.com/report/dermatological-drugs-global-market-report
How Is the Dermatological Drugs Market Defined and What Are Its Core Parameters?
Dermatological drugs refer to medications designed to treat conditions affecting the skin, hair, and nails by reducing inflammation, controlling infections, or managing symptoms such as itching and redness. These drugs play a crucial role in dermatology by addressing both common and severe skin disorders, improving patient comfort and quality of life.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21166
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model